ImmunoPrecise Antibodies Ltd., together with its subsidiaries, operates as a biotherapeutic research and technology company in Canada and internationally. It provides NonaVac DNA for complex protein classes, including GPCRs and ion channels; and Rapid Prime, a positive monoclonal antibodies for generating anti-idiotypic antibodies, and producing monoclonal antibodies against conformational epitopes. The company also offers syngeneic cell line for immunization and screening; and peptide production for subsequent antibody discovery campaign. In addition, it provides B cell select platform which allows for the interrogation of animal antibody repertoire; screening of the immune repertoire of rabbits and chickens and select the desired antibody directly from the B cells; single step hybridoma, a semi-solid media to grow mouse and rat hybridomas; and DeepDisplay, a combination of transgenic animal platform and custom IPA phage display antibody selection. The company also offers phage display, a custom immune libraries from multiple species; and CAR development, an adaptable antibody which allows the inclusion of functional data early in the screening funnel. Further, it provides silico developability, a profiling toolset for antibody lead candidates; and vitro analytical tools for the study of various critical quality attributes. Additionally, the company offers LucinaTech, an antibody humanization to identify essential framework and CDR residues; antibody affinity maturation for therapeutic and diagnostic application; and antibody chimerization for cloning and production of variable antibody domain. It also provides Eurofins preclinical services; hybrid service model, a service model designed to reduce time and risk with custom technologies and applications; and breadth and depth to accelerate assay development, screening cascades, drug candidate validation, and new biotherapeutic concepts. The company was incorporated in 1983 and is headquartered in Victoria, Canada.
Date |
For |
Estimate |
Reported |
Surprise |
surprise % |
2024-07-08 |
2024-04 |
-0.1 |
N/A |
N/A |
N/A |
2024-03-14 |
2024-01 |
-0.08 |
-0.08 |
N/A |
N/A |
2023-12-14 |
2023-10 |
-0.09 |
-0.07 |
0.02 |
22.22% |
2023-12-14 |
2023-10 |
-0.09 |
N/A |
N/A |
N/A |
2023-09-14 |
2023-07 |
-0.17 |
-0.11 |
0.06 |
35.29% |
2023-09-14 |
2023-07 |
-0.17 |
N/A |
N/A |
N/A |
Date |
Name |
Relation |
Quantity |
Description |
2022-11-03 |
Bath (Jennifer Lynne) |
Senior Officer of Issuer |
108.82K |
Acquisition or disposition in the public market |
2022-04-12 |
Brands (Ingrid Maria Henri) |
Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) |
0.00 |
Opening Balance-Initial SEDI Report |
2022-08-16 |
Burke (Robert D) |
Director of Issuer |
31.00K |
Acquisition or disposition in the public market |
2022-08-14 |
Chabot (Frederick) |
Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6) |
0.00 |
Acquisition or disposition in the public market |
2022-04-06 |
Duplantis (Barry Neil) |
Senior Officer of Issuer |
1.20K |
Acquisition or disposition in the public market |
2022-09-14 |
McConn (Brad) |
Senior Officer of Issuer |
8.00K |
Acquisition or disposition in the public market |
Institution Ownership
...
Report Date |
Organization |
Position |
Value |
Percentage |
2023-06-29 |
Ingalls & Snyder |
1.06M |
3.14M |
4.23% |
2023-06-29 |
Bank of Montreal/Can/ |
208.11K |
616.01K |
0.83% |
2023-06-29 |
Cibc World Markets, Inc. |
42.43K |
125.58K |
0.17% |
2023-06-29 |
Citadel Advisors Llc |
34.78K |
102.96K |
0.14% |
2023-06-29 |
Dimensional Fund Advisors LP |
26.74K |
79.14K |
0.11% |
2023-06-29 |
Gradient Capital Advisors, LLC |
26.81K |
79.35K |
0.11% |
Report Date |
Organization |
Position |
Value |
Percentage |
2023-05-30 |
Fidelity NASDAQ Composite Index Fund |
17.48K |
55.25K |
0.07% |
2023-07-30 |
DFA U.S. Core Equity 1 Portfolio |
3.81K |
9.61K |
0.02% |
2023-07-30 |
DFA U.S. Core Equity 2 Portfolio |
2.25K |
5.67K |
0.01% |
2023-07-30 |
DFA U.S. Vector Equity Portfolio |
2.80K |
7.06K |
0.01% |
2023-07-30 |
Dimensional ETF Tr-Dimensional U.S. Core Equity 2 ETF |
2.58K |
6.50K |
0.01% |
Split |
Date |
1 : 5 |
2020-11-23 |
1 : 3 |
2016-09-02 |
4 : 1 |
2013-05-30 |
4 : 1 |
2013-04-12 |
1 : 10 |
2011-09-13 |